REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks flat despite rise in cyclicals

Tue, 12th Jan 2021 10:06

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Cyclical stocks lead gains again

* London's FTSE hit by stronger pound

* Maersk gains after Berenberg upgrade
(Updates to market close)

By Sruthi Shankar

Jan 12 (Reuters) - European stocks closed flat on Tuesday,
with economically sensitive sectors including banks, automakers
and oil supporting markets across the continent.

The regional STOXX 600 index closed up 0.05% after
a mixed session, while Germany's DAX rose 0.1%,
France's CAC inched 0.2% lower and Britain's FTSE 100
fell 0.7%.

Investors are awaiting the start of the U.S. earnings season
this week as well as clarity on fiscal spending plans under
incoming U.S. President Joe Biden, who takes office on Jan. 20.

In Europe, automakers jumped 1.7% to lead gains
after Renault, BMW and VW
reported 2020 sales.

Their U.S. carmaking rivals also got a boost after General
Motors announced its entry into the growing electric
delivery vehicle business.

Other cyclicals such as banks, travel and leisure
and oil and gas extended last week's rally on
hopes that a larger U.S. stimulus under the incoming Biden
administration will spur faster economic recovery.

Oil majors BP and Royal Dutch Shell gained
close to 2% as crude prices hit an 11-month high on tighter
supply and expectations for a drop in U.S. inventories.

Still, losses in defensive sectors such as healthcare,
utilities and consumer staples checked gains in most markets.

"Investors are still wondering where the next big catalyst
for further upside will come from, and are painfully aware that
the COVID-19 crisis remains untamed despite the introduction of
vaccination programmes," Chris Beauchamp, chief market analyst
at IG wrote in a client note.

Britain's exporter-heavy FTSE 100 underperformed
other European markets, hit by a stronger pound and a surge in
new COVID-19 cases.

Companies listed on Europe's STOXX 600 are expected to
report a 26.3% drop in fourth-quarter earnings, data from
Refinitiv I/B/E/S shows, as restrictions to control soaring
coronavirus cases slowed an economic recovery.

That comes ahead of a clear improvement predicted for the
first two quarters of 2021, when earnings are set to rise 40.4%
and 75.1% respectively.

Maersk rose 3.4% after brokerage Berenberg
upgraded the Danish shipping company's shares to "buy", saying
earnings momentum driven by freight prices could see it run
higher.

Swiss online pharmacy chain Zur Rose hit a record
high, surging almost 15% to the top of STOXX 600, after BofA
Global Research started coverage with "buy" rating.
(Reporting by Amal S and Sruthi Shankar in Bengaluru; Editing
by Subhranshu Sahu, Arun Koyyur and Alexander Smith)

More News
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.